These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 29956518)

  • 1. [In process].
    Koczorek M
    Med Monatsschr Pharm; 2016 Sep; 39(9):400-1. PubMed ID: 29956518
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of recombinant factor VIIa for bleeding in children with Glanzmann thrombasthenia.
    Cağlar K; Cetinkaya A; Aytaç S; Gümrük F; Gürgey A
    Pediatr Hematol Oncol; 2003 Sep; 20(6):435-8. PubMed ID: 14631616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant activated factor VII combined with local measures in preventing bleeding from invasive dental procedures in patients with Glanzmann thrombasthenia.
    Chuansumrit A; Suwannuraks M; Sri-Udomporn N; Pongtanakul B; Worapongpaiboon S
    Blood Coagul Fibrinolysis; 2003 Feb; 14(2):187-90. PubMed ID: 12632030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful use of recombinant factor VIIa (NovoSeven) during cardiac surgery in a pediatric patient with Glanzmann thrombasthenia.
    Yilmaz BT; Alioglu B; Ozyurek E; Akay HT; Mercan S; Ozbek N
    Pediatr Cardiol; 2005; 26(6):843-5. PubMed ID: 15690232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant-activated coagulation factor VIIa (NovoSeven): current development.
    Weiskopf RB
    Vox Sang; 2007 May; 92(4):281-8. PubMed ID: 17456151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant factor VIIa and the trauma patient.
    Criddle LM
    J Emerg Nurs; 2006 Oct; 32(5):404-8. PubMed ID: 16997029
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of bleeding in patients with platelet disorders: is there a place for recombinant factor VIIa?
    Laurian Y
    Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():37-40. PubMed ID: 12214146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of recombinant factor VIIa in inherited platelet disorders.
    Kaleelrahman M; Minford A; Parapia LA
    Br J Haematol; 2004 Apr; 125(1):95-6. PubMed ID: 15015980
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention and treatment of major blood loss.
    Detry O; De Roover A; Honoré P
    N Engl J Med; 2007 Sep; 357(12):1261; author reply 1261. PubMed ID: 17891839
    [No Abstract]   [Full Text] [Related]  

  • 10. Is recombinant FVIIa the magic bullet in the treatment of major bleeding?
    Spahn DR; Tucci MA; Makris M
    Br J Anaesth; 2005 May; 94(5):553-5. PubMed ID: 15814804
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of rFVIIa in 4 children with Glanzmann thrombasthenia.
    Valentino LA
    J Pediatr Hematol Oncol; 2006 Oct; 28(10):653-8. PubMed ID: 17023825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of recombinant factor VIIa in a patient with essential thrombocythaemia with uncontrolled surgical bleeding.
    Cervera JS; Mena-Durán AV; Piqueras CS
    Thromb Haemost; 2005 Feb; 93(2):383-4. PubMed ID: 15711760
    [No Abstract]   [Full Text] [Related]  

  • 13. Recombinant activated factor VII and epsilon aminocaproic acid treatment of a patient with Glanzmann's thrombasthenia for nasal polipectomy.
    Gunaydin B; Ozkose Z; Pezek S
    J Anesth; 2007; 21(1):106-7. PubMed ID: 17285428
    [No Abstract]   [Full Text] [Related]  

  • 14. Bleeding and surgery in children with Glanzmann thrombasthenia with and without the use of recombinant factor VII a.
    Hennewig U; Laws HJ; Eisert S; Göbel U
    Klin Padiatr; 2005; 217(6):365-70. PubMed ID: 16307424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing uncontrolled hemorrhage in trauma and surgery: a novel and promising approach.
    Hardy JF
    Can J Anaesth; 2002 Dec; 49(10):S4-6. PubMed ID: 12545999
    [No Abstract]   [Full Text] [Related]  

  • 16. [Place of recombinant activated factor VII in the treatment of severe haemorrhage in paediatric patients].
    Veyckemans F
    Ann Fr Anesth Reanim; 2009; 28(7-8):676-7. PubMed ID: 19574019
    [No Abstract]   [Full Text] [Related]  

  • 17. Recombinant factor VIIa is a pan-hemostatic agent?
    Aledort LM
    Thromb Haemost; 2000 May; 83(5):637-8. PubMed ID: 10823252
    [No Abstract]   [Full Text] [Related]  

  • 18. Low-dose recombinant activated factor VII in massively transfused trauma patients with coagulopathy.
    Bauzá G; Hirsch E; Burke P; Quillen K
    Transfusion; 2007 Apr; 47(4):749-51. PubMed ID: 17381636
    [No Abstract]   [Full Text] [Related]  

  • 19. Recombinant activated factor VII and the anaesthetist.
    Welsby IJ; Monroe DM; Lawson JH; Hoffmann M
    Anaesthesia; 2005 Dec; 60(12):1203-12. PubMed ID: 16288618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant activated factor VII: mechanisms of action and current indications.
    Franchini M; Lippi G
    Semin Thromb Hemost; 2010 Jul; 36(5):485-92. PubMed ID: 20632246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.